ProPhase Labs Inc (PRPH) USD0.0005

Sell:$0.35Buy:$0.36$0.00 (0.22%)

Prices delayed by at least 15 minutes
Sell:$0.35
Buy:$0.36
Change:$0.00 (0.22%)
Prices delayed by at least 15 minutes
Sell:$0.35
Buy:$0.36
Change:$0.00 (0.22%)
Prices delayed by at least 15 minutes

Company Information

About this company

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.

Key people

Ted William Karkus
Chairman of the Board, Chief Executive Officer
Stuart Hollenshead
Chief Operating Officer
Louis Gleckel
Independent Director
Warren Hirsch
Independent Director
Click to see more

Key facts

  • EPIC
    PRPH
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • ISIN
    US74345W1080
  • Market cap
    $14.87m
  • Employees
    96
  • Shares in issue
    50.23m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.